Translational issues in precision medicine in neuropathic pain

被引:17
|
作者
Dickenson, Anthony H. [1 ]
Patel, Ryan [1 ]
机构
[1] UCL, Dept Neurosci Physiol & Pharmacol, Gower St, London WC1E 6BT, England
来源
CANADIAN JOURNAL OF PAIN-REVUE CANADIENNE DE LA DOULEUR | 2020年 / 4卷 / 01期
关键词
translational research; neuropathic pain; sensory phenotype; precision medicine; animal models of neuropathy;
D O I
10.1080/24740527.2020.1720502
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neuropathic pain remains poorly treated, with most new drugs falling through the translational gap. The traditional model of bench-to-bedside research has relied on identifying new mechanisms/targets in animal models and then developing clinical applications. Several have advocated bridging the translational gap by beginning with clinical observations and back-translating to animal models for further investigation of mechanisms. There is good evidence that phenotyping of patients through quantitative sensory testing can lead to improved treatment selection and hence improved patient outcomes. This practice has been widely adopted in clinical investigations, but its application in preclinical research is not mainstream. In this review, we retrospectively examine our historical rodent data sets with the aim of reconsidering drug effects on sensory neuronal endpoints, their alignment with clinical observations, and how these might guide future clinical studies. RESUME La douleur neuropathique reste mal traitee, alors que la plupart des nouveaux medicaments ne reussissent pas a franchir le fosse translationnel. Le modele traditionnel de la recherche, du laboratoire au chevet du patient, repose sur l'identification de nouveaux mecanismes ou cibles dans des modeles animaux, suivie du developpement d'applications cliniques. Certains preconisent de combler le fosse de la recherche translationnelle en commencant par des observations cliniques et en les transposant ensuite sur des modeles animaux afin d'approfondir l'etude des mecanismes. Il est bien etabli que le phenotypage des patients par des tests sensoriels quantitatifs peut conduire a une meilleure selection des traitements et, par consequent, a de meilleurs resultats pour les patients. Ces pratiques ont ete largement adoptees dans les enquetes cliniques, mais leur application dans la recherche preclinique n'est pas generalisee. Dans cette revue, nous examinons retrospectivement nos ensembles de donnees historiques sur les rongeurs dans le but de reconsiderer les effets des medicaments sur les parametres neuronaux sensoriels, leur alignement avec les observations cliniques et la maniere dont celles-ci pourraient orienter les etudes cliniques futures.
引用
收藏
页码:30 / 38
页数:9
相关论文
共 50 条
  • [31] Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans
    Arendt-Nielsen, Lars
    Klitgaard, Henrik
    Hansen, Stine N.
    SCANDINAVIAN JOURNAL OF PAIN, 2024, 24 (01)
  • [32] Allopregnanolone and Progesterone in Experimental Neuropathic Pain: Former and New Insights with a Translational Perspective
    Susana Laura González
    Laurence Meyer
    María Celeste Raggio
    Omar Taleb
    María Florencia Coronel
    Christine Patte-Mensah
    Ayikoe Guy Mensah-Nyagan
    Cellular and Molecular Neurobiology, 2019, 39 : 523 - 537
  • [33] Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm
    A. Taneja
    O. Della Pasqua
    M. Danhof
    European Journal of Clinical Pharmacology, 2017, 73 : 1219 - 1236
  • [34] A comprehensive review of traditional Chinese medicine in treating neuropathic pain
    Hu, Naihua
    Liu, Jie
    Luo, Yong
    Li, Yunxia
    HELIYON, 2024, 10 (17)
  • [35] Capsaicin for Neuropathic Pain: Linking Traditional Medicine and Molecular Biology
    Haanpaa, Maija
    Treede, Rolf-Detlef
    EUROPEAN NEUROLOGY, 2012, 68 (05) : 264 - 275
  • [36] Integrative neuromuscular medicine: Neuropathy and neuropathic pain: Consider the alternatives
    Rowin, Julie
    MUSCLE & NERVE, 2019, 60 (02) : 124 - 136
  • [37] Building a rheumatology biobank for reliable basic/translational research and precision medicine
    Assirelli, Elisa
    Naldi, Susanna
    Brusi, Veronica
    Ciaffi, Jacopo
    Lisi, Lucia
    Mancarella, Luana
    Pignatti, Federica
    Pulsatelli, Lia
    Faldini, Cesare
    Ursini, Francesco
    Neri, Simona
    FRONTIERS IN MEDICINE, 2023, 10
  • [38] Models of cardiovascular surgery biobanking to facilitate translational research and precision medicine
    Zhu, YingYan
    Jackson, Dan
    Hunter, Benjamin
    Beattie, Lorna
    Turner, Lisa
    Hambly, Brett D.
    Jeremy, Richmond W.
    Malecki, Cassandra
    Robertson, Elizabeth N.
    Li, Amy
    dos Remedios, Cris
    Richmond, David
    Semsarian, Christopher
    O'Sullivan, John F.
    Bannon, Paul G.
    Lal, Sean
    ESC HEART FAILURE, 2022, 9 (01): : 21 - 30
  • [39] The Development of Translational Biomarkers as a Tool for Improving the Understanding, Diagnosis and Treatment of Chronic Neuropathic Pain
    Buckley, David A.
    Jennings, Elaine M.
    Burke, Nikita N.
    Roche, Michelle
    McInerney, Veronica
    Wren, Jonathan D.
    Finn, David P.
    McHugh, Patrick C.
    MOLECULAR NEUROBIOLOGY, 2018, 55 (03) : 2420 - 2430
  • [40] Mast Cells, microRNAs and Others: The Role of Translational Research on Colorectal Cancer in the Forthcoming Era of Precision Medicine
    Sammarco, Giuseppe
    Gallo, Gaetano
    Vescio, Giuseppina
    Picciariello, Arcangelo
    De Paola, Gilda
    Trompetto, Mario
    Curro, Giuseppe
    Ammendola, Michele
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 17